PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes |
| Sentences | 526 |
| PubMedID- 20550690 | The risk factors were presented in the questionnaire in the following order: higher age, hyperlipidemia, diabetes, a family history of cardiovascular disease, atrial fibrillation, hypertension, overweight, regular physical exercise, excessive alcohol consumption, previous stroke/tia, carotid stenosis, smoking and ischaemic heart disease. |
| PubMedID- 23951331 | This prospective cohort study demonstrates the value of ldl particle size measurements in the prediction of changes in metabolic status and cardiovascular disease in patients with diabetes or prediabetes. |
| PubMedID- 20210989 | In a more recent controlled study performed in our center 6, it was found that blood flow alterations (stenoses and/or occlusions) demonstrated in temporal arteries with doppler ultrasonography are neither specific nor sensitive for gca, since these findings were equally common among elderly individuals or patients with macrovascular disease associated with diabetes mellitus or stroke, due to the temporal artery atherosclerotic changes. |
| PubMedID- 22285702 | We investigated the effect of rhr on the incidence of type 2 diabetes mellitus (t2dm) in patients with clinically manifest vascular diseases. |
| PubMedID- 25708055 | This study aimed to assess the effects of active and passive smoking exposure on the development of cardiovascular disease in patients with type 2 diabetes mellitus. |
| PubMedID- 25990316 | vascular disease in diabetes mellitus. |
| PubMedID- 26173772 | Confounders for this association were age, ethnicity, season, sun exposure, diabetes duration, presence of cardiovascular disease, egfr, alkaline phosphatase and ldl cholesterol. |
| PubMedID- 25922835 | Resistin has been recognised as an adipocytokine positively correlated with insulin resistance and type 2 diabetes and is predictive of cardiovascular disease . |
| PubMedID- 22906083 | Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. |
| PubMedID- 23323191 | The pathophysiology underlying cognitive change in type 2 diabetes is examined with reference to vascular disease, hypoglycaemia, inflammation and insulin levels. |
| PubMedID- 25685383 | Trends in the risk for cardiovascular disease among adults with diabetes in oman. |
| PubMedID- 23160724 | The risk of death from cardiovascular disease among people with diabetes who reported a moderate to high physical activity level was similar to inactive people without diabetes. |
| PubMedID- 24354901 | Model 3: model 2 plus adjustment for medications (for hypertension, diabetes, and dyslipidemia), history of stroke or cardiovascular disease, daily alcohol consumption (versus infrequent/no alcohol consumption), and regular exercise (≥30 min exercise per session >2 times/week versus infrequent exercise). |
| PubMedID- 25877139 | Objective: to investigate if a six-year intensive lifestyle intervention in people with pre-diabetes lead to reduction of cardiovascular events and cardiovascular disease (cvd) mortality in subsequent 23 years. |
| PubMedID- 26244041 | A recent review identified twelve risk equations for the prediction of cardiovascular disease in subjects with type 2 diabetes mellitus (t2dm) 6. |
| PubMedID- 20186491 | We then discuss the implications of these studies for current management and for new approaches for the prevention and treatment of cardiovascular disease in patients with diabetes mellitus. |
| PubMedID- 25927959 | Background: hyperglycemia has been recognized as a primary factor in endothelial barrier dysfunction and in the development of micro- and macrovascular diseases associated with diabetes, but the underlying biochemical mechanisms remain elusive. |
| PubMedID- 22184101 | Study selection: a study was eligible when it described the development, validation or impact assessment of a model that was constructed to predict the occurrence of cardiovascular disease in people with type 2 diabetes, or when the model was designed for use in the general population but included diabetes as a predictor. |
| PubMedID- 22851545 | Background: endothelial damage and dysfunction are crucial mediators that link diabetes mellitus with atherosclerotic cardiovascular disease. |
| PubMedID- 26292807 | Patients’ characteristics including metabolic co-morbidities and leucocyte counts as well as treatment characteristics are summarized in table 1. comorbidities included diabetes in 15.1 % of patients, cardiovascular disease in 34.6 % and hypertension in 45.7 %. |
| PubMedID- 23275224 | While cardiovascular diseases in diabetes are macrovascular in origin, retinopathy is microvascular, and each has distinct and different set of major etiological factors. |
| PubMedID- 21291555 | Apart from the combination of cardiovascular disease with comorbid diabetes reported by 60.2%, arthritis was consistently among the most commonly reported comorbid condition, being reported by a third of people with the index conditions. |
| PubMedID- 25848912 | The association between circulating mmps and macrovascular disease in patients with type 1 diabetes has not been investigated, while studies on the associations between mmp levels and microvascular complications seem contradictory. |
| PubMedID- 19754853 | Methods: cardiovascular disease patients with diabetes mellitus (group a, n = 14) and nondiabetic patients with cvd only (group b, n = 10) took atorvastatin 80 mg per day for a period of 8-10 weeks. |
| PubMedID- 22389337 | Since diabetes increases the risk of cardiovascular disease, for example, the impact of interventions for the treatment of hyperglycaemia in reducing this risk should be assessed. |
| PubMedID- 26429401 | Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in sweden: a nationwide, matched, observational cohort study. |
| PubMedID- 22665334 | As an example, cpgs for cardiovascular diseases in diabetes mellitus have been developed.24 these cpgs contain detailed practical instructions for management of cardiovascular diseases in diabetic patients.24 some studies have reported that cpgs can improve the health outcomes of patients in terms of in-hospital mortality or los and concluded that cpgs were a significant independent predictor of clinical outcomes of patients.25,26 therefore, we think that the preparation and institution of cpgs for bleeding peptic ulcers with comorbid diabetes mellitus would be a promising policy implementation for improving the short-term clinical outcomes of these patients. |
| PubMedID- 22809064 | Both ra and diabetes increase the risk of cardiovascular disease (cvd), yet understanding of how comorbid ra impacts the receipt of guideline-based diabetes care is limited. |
| PubMedID- 26003174 | The pathophysiology of vascular disease in diabetes involves abnormalities in endothelial and vsmcs, and alterations in platelet function . |
| PubMedID- 20415560 | Vitamin e reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. |
| PubMedID- 21963020 | Preliminary evidence in support of fruit intake for the prevention of cardiovascular disease in patients with type 2 diabetes mellitus (t2dm) is still limited. |
| PubMedID- 23049260 | Jablecka et al treated 38 patients who had peripheral vascular disease with type ii diabetes using l-arginine.26 the total study population was 50 (38 subjects and twelve controls). |
| PubMedID- 21470634 | Background: accelerated cardiovascular disease in patients with type i diabetes (tid) is a well-described condition and serious clinical obstacle. |
| PubMedID- 21270199 | Thus, ages may explain, in part, the increased cardiovascular disease and mortality attributable to type 1 diabetes and constitute a specific target for treatment in these patients. |
| PubMedID- 22844422 | Although most early studies so far have been concerned by the concept that factors secreted from the gut endocrine system participate in the regulation of gastrointestinal functions, growing evidence underlines their functions in metabolic pathways and in the pathophysiology of various metabolic diseases, including obesity, insulin resistance and diabetes, which lead to cardiovascular diseases. |
| PubMedID- 25899452 | Statins have been shown to be beneficial in reducing cardiovascular disease (cvd) in patients with type 2 diabetes , but it remains unclear whether these effects can be explained by their lipid-lowering effects only. |
| PubMedID- 21933841 | Purpose: to evaluate myocardial microvascular disease in patients with type 2 diabetes mellitus (dm) using myocardial contrast echocardiography (mce) and to report on its diagnostic accuracy using single photon emission tomography (spect) as reference test. |
| PubMedID- 23250799 | However, as diabetes may be associated with macrovascular disease prior to esrd, adjusting for diabetes may control for some residual confounding that may have existed in the overall model. |
| PubMedID- 21990060 | Cardiovascular disease patients with diabetes mellitus type 2. |
| PubMedID- 24059905 | The risk factors for ischemic stroke include aging, hypertension, diabetes, smoking, history of cardiovascular diseases, atrial fibrillation, and left ventricular hypertrophy . |
| PubMedID- 22711281 | Most diabetes-related complications and causes of death arise from cardiovascular disease and end-stage renal disease. |
| PubMedID- 24147047 | To stratify the subjects, comorbid conditions and other risk factors such as congestive heart failure, hypertension, age ≥75, diabetes, history of stroke, vascular disease, age 65–74, and sex category were taken into account according to the cha2ds2-vasc or chads2 scheme criteria . |
| PubMedID- 22422191 | Mortality of cardiovascular diseases in patients with type 1 diabetes is increased 2- to 20-fold compared to non-diabetic individuals. |
| PubMedID- 24920930 | Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. |
| PubMedID- 22322078 | To date, the drug approach to prevention of microvascular disease starting with pre-diabetes has not been evaluated. |
| PubMedID- 24855344 | Several large-scale, prospective, randomized trials have documented that lowering glycemic levels can prevent the development of microvascular disease in people with type 2 diabetes mellitus (t2dm). |
| PubMedID- 24349248 | As described above, the decrease of serum bfgf appears in infarction, stroke and peripheral vascular disease associated with diabetes . |
| PubMedID- 24728837 | The presence of cardiovascular diseases was significantly associated with diabetes mellitus in patients with copd. |
| PubMedID- 22647032 | The pathophysiology of vascular disease in diabetes involves abnormalities in endothelial cells, vascular smooth muscle cells, and monocytes. |
| PubMedID- 22440125 | Microalbuminuria is one of the strongest predictors of both adverse renal and cardiovascular disease (cvd) outcomes in patients with type 2 diabetes mellitus. |